Advertisement
Tarsus Pharmaceuticals, Inc. (TARS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 46.40 |
| Open | 46.63 |
| Bid | 48.03 x 100 |
| Ask | 48.39 x 100 |
| Day's Range | 45.98 - 48.50 |
| 52 Week Range | 15.60 - 52.99 |
| Volume | |
| Avg. Volume | 750,674 |
| Market Cap | 1.844B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.75 |
| Earnings Date | Nov 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 65.33 |
ZacksWall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 41.1% in Tarsus Pharmaceuticals (TARS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Simply Wall St.Tarsus Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
Tarsus Pharmaceuticals ( NASDAQ:TARS ) Third Quarter 2024 Results Key Financial Results Revenue: US$48.1m (up by...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.